No stock market follow-through day — here's why that's good news. Crude oil prices dived ahead of a key inflation report. Read More...
Motley Fool
Why Moderna Stock Was a Big Winner on Wednesday
In the wake of that announcement, the biotech company’s stock price shot more than 10% higher for the session. This happy investor is Josh Brown, a high-profile financial writer, blogger, and CNBC commentator, who revealed that he’d bought Moderna stock at what he termed a “ludicrous” price of $125 per share. In an interview that aired on CNBC, Brown asserted that Moderna has far more value than its recent share prices would indicate.
